Consultant Surgical Gastroenterology, Hepatobiliary and Liver Transplant, Shalby hospitals, Ahmedabad, 380054, India.
Hernia. 2023 Apr;27(2):235-244. doi: 10.1007/s10029-022-02657-z. Epub 2022 Aug 3.
The primary objectives were to evaluate Surgical Site Occurrences (SSO) and Surgical Site Occurrences requiring procedural Intervention (SSOPI) after open transversus abdominis release and to study various factors affecting it. Secondary objectives were to evaluate Surgical Site Infections (SSI), recurrence rates and overall complications after transversus abdominis release (TAR) and the factors responsible for those.
We searched PUBMED, SCOPUS and Cochrane databases with keywords "transversus abdominis release" or "TAR" OR "Surgical Site Occurrences" OR "posterior component separation AND "outcomes" as per PRISMA 2020 and MOOSE guidelines. Full texts and English literature studies were included, studies mentioning outcomes for open transversus abdominis release for ventral hernia were included and studies with robotic transversus abdominis release were excluded. Percentage occurrences of SSO, SSOPI, SSI, recurrence and overall complications after TAR were evaluated. Random effect meta-analysis with restricted maximum likelihood methods was used for meta-analysis. Heterogeneity was analysed using I statistics. Publication bias with eager's test and funnel plots. Meta0regression analysis was done to evaluate factors affecting the heterogeneity. JASP 0.16.2 software was used for meta-analysis.
Twenty-two studies including 5284 patients who underwent TAR for ventral hernia were included in systematic review and meta-analysis. Overall pooled SSO, SSOPI, Overall Complications, SSI and recurrence rates were 21.72% [95% C.I 17.18-26.27%], 9.82% [95% C.I 7.64 -12%], 33.34% [95% C.I. 27.43-39.26%], 9.13% [95% C.I. 6.41-11.84] and 1.6% [0.78-2.44], respectively. Heterogeneity was significant in all the analysis. Age (p < 0.001), sex (p < 0.001), BMI (p < 0.001),presence of comorbidities (p < 0.001), prior recurrence, defect size (p < 0.001) and current or past history of tobacco exposure were associated with SSO in multivariate meta-regression analysis. Defect size (p = 0.04) was associated with SSOPI. Age (p = 0.011), BMI (p = 0.013), comorbidities (p < 0.01), tobacco exposure (p = 0.018), prior recurrence (p < 0.01) and sex (p < 0.01) were associated with overall complications.
Open transversus abdominis release is associated with high rates of SSO, SSOPI, SSI and overall complications but recurrence rates are low. Various preoperative factors mentioned may be responsible for heterogeneity across studies.
主要目的是评估开放式腹横肌释放术后手术部位发生(SSO)和需要手术干预的手术部位发生(SSOPI),并研究影响这些的各种因素。次要目的是评估开放式腹横肌释放术后手术部位感染(SSI)、复发率和总体并发症,以及导致这些的因素。
我们按照 PRISMA 2020 和 MOOSE 指南,在 PUBMED、SCOPUS 和 Cochrane 数据库中使用“transversus abdominis release”或“TAR”或“Surgical Site Occurrences”或“posterior component separation AND outcomes”等关键字进行搜索。纳入全文和英文文献研究,纳入提及开放式腹横肌释放术治疗腹疝结局的研究,并排除使用机器人腹横肌释放术的研究。评估 TAR 后 SSO、SSOPI、SSI、复发和总体并发症的发生率。使用受限最大似然法进行随机效应荟萃分析。使用 I 统计量分析异质性。使用 eager 检验和漏斗图评估发表偏倚。进行 Meta0regression 分析以评估影响异质性的因素。使用 JASP 0.16.2 软件进行荟萃分析。
系统评价和荟萃分析共纳入 22 项研究,包括 5284 例接受 TAR 治疗腹疝的患者。总体 SSO、SSOPI、总体并发症、SSI 和复发率分别为 21.72% [95% C.I 17.18-26.27%]、9.82% [95% C.I 7.64-12%]、33.34% [95% C.I. 27.43-39.26%]、9.13% [95% C.I. 6.41-11.84%]和 1.6% [0.78-2.44%]。所有分析的异质性均显著。多元荟萃回归分析显示,年龄(p<0.001)、性别(p<0.001)、BMI(p<0.001)、合并症(p<0.001)、既往复发、缺损大小(p<0.001)和当前或既往吸烟史与 SSO 相关。缺损大小(p=0.04)与 SSOPI 相关。年龄(p=0.011)、BMI(p=0.013)、合并症(p<0.01)、吸烟史(p=0.018)、既往复发(p<0.01)和性别(p<0.01)与总体并发症相关。
开放式腹横肌释放术与 SSO、SSOPI、SSI 和总体并发症发生率高有关,但复发率较低。提到的各种术前因素可能是导致研究之间异质性的原因。